Td Private Client Wealth LLC Neurocrine Biosciences Inc Transaction History
Td Private Client Wealth LLC
- $3.63 Trillion
- Q1 2025
A detailed history of Td Private Client Wealth LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 144 shares of NBIX stock, worth $17,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144
Previous 79
82.28%
Holding current value
$17,943
Previous $10.8 Million
47.68%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$690 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$606 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$333 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...